JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB128171

Anti-TRIP13/PCH2 antibody

Be the first to review this product! Submit a review

|

(7 Publications)

Rabbit Polyclonal TRIP13/PCH2 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human TRIP13 aa 50-100.

View Alternative Names

PCH2, TRIP13, Pachytene checkpoint protein 2 homolog, Human papillomavirus type 16 E1 protein-binding protein, Thyroid hormone receptor interactor 13, Thyroid receptor-interacting protein 13, 16E1-BP, HPV16 E1 protein-binding protein, TR-interacting protein 13, TRIP-13

3 Images
Immunoprecipitation - Anti-TRIP13/PCH2 antibody (AB128171)
  • IP

Unknown

Immunoprecipitation - Anti-TRIP13/PCH2 antibody (AB128171)

Detection of TRIP13/PCH2 by Western Blot of Immunprecipitate.
a128171, at 1 μg/ml, staining TRIP13/PCH2 in HeLa whole cell lysate immunoprecipitated using ab128171 at 6 μg/mg lysate (1 mg/IP; 20% of IP loaded/lane).
Lane 2 : Control IgG.
Detection : Chemiluminescence with exposure time of 10 seconds.

All lanes:

Immunoprecipitation - Anti-TRIP13/PCH2 antibody (ab128171)

Predicted band size: 49 kDa

false

Western blot - Anti-TRIP13/PCH2 antibody (AB128171)
  • WB

Unknown

Western blot - Anti-TRIP13/PCH2 antibody (AB128171)

All lanes:

Western blot - Anti-TRIP13/PCH2 antibody (ab128171) at 0.1 µg/mL

Lane 1:

HeLa whole cell lysate at 50 µg

Lane 2:

HeLa whole cell lysate at 15 µg

Lane 3:

293T whole cell lysate at 50 µg

Lane 4:

Jurkat whole cell lysate at 50 µg

Predicted band size: 49 kDa

true

Exposure time: 3min

Western blot - Anti-TRIP13/PCH2 antibody (AB128171)
  • WB

Lab

Western blot - Anti-TRIP13/PCH2 antibody (AB128171)

Anti-TRIP13 antibody (ab128171) staining at 1/2000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab128171 was shown to bind specifically to TRIP13. A band was observed at 48 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in TRIP13 knockout cell line. To generate this image, wild-type and TRIP13 knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-TRIP13/PCH2 antibody (ab128171) at 1/2000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human TRIP13 (PCH2) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-trip13-pch2-knockout-hek-293t-cell-line-ab266495'>ab266495</a>)

Lane 2:

TRIP13 knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human TRIP13 (PCH2) knockout HEK-293T cell lysate (<a href='/en-us/products/cell-lysates/human-trip13-pch2-knockout-hek-293t-cell-lysate-ab258736'>ab258736</a>)

Lane 3:

HCT 116 cell lysate at 20 µg

Lane 4:

SW480 cell lysate at 20 µg

Predicted band size: 49 kDa

Observed band size: 48 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP

applications

Immunogen

Synthetic Peptide within Human TRIP13 aa 50-100. The exact immunogen used to generate this antibody is proprietary information.

Q15645

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "2-10 µg/mg of lysate", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000 - 1/10000", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Chimpanzee": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Elephant": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Gorilla": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Orangutan": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Pig": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7 - 8 Preservative: 0.09% Sodium azide Constituents: 99% Tris citrate/phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TRIP13 also known as PCH2 is a protein involved in the regulation of chromosome dynamics during meiosis and mitosis. It is approximately 48 kDa in size. TRIP13 plays an important role in promoting the disassembly of the synaptonemal complex and ensuring proper chromosome segregation. This protein is expressed in various tissues but shows higher levels in testis suggesting its importance in reproductive cell division.
Biological function summary

TRIP13 contributes to efficient cell cycle progression by participating in the spindle assembly checkpoint (SAC). It forms part of the mitotic checkpoint complex ensuring that chromosomes are correctly attached to the spindle microtubules before progression through mitosis. TRIP13 works in conjunction with other proteins like MAD2 and BUB1 to maintain genomic stability.

Pathways

TRIP13 is involved in the cell cycle control and DNA repair pathways. It influences the mitotic spindle checkpoint interacting with proteins such as MAD2 which ensures that cells do not proceed to anaphase until all chromosomes reach proper alignment. TRIP13 also plays a role in homologous recombination repair by regulating the processing of recombination intermediates.

TRIP13 has been implicated in cancer and infertility. Its overexpression or mutation has been linked to tumor progression and resistance to certain chemotherapeutic agents due to its role in chromosome segregation and genomic stability. Additionally TRIP13 dysfunction may contribute to infertility through its impact on meiosis with potential interactions with proteins involved in reproductive processes such as SYCP3.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a key role in chromosome recombination and chromosome structure development during meiosis. Required at early steps in meiotic recombination that leads to non-crossovers pathways. Also needed for efficient completion of homologous synapsis by influencing crossover distribution along the chromosomes affecting both crossovers and non-crossovers pathways. Also required for development of higher-order chromosome structures and is needed for synaptonemal-complex formation. In males, required for efficient synapsis of the sex chromosomes and for sex body formation. Promotes early steps of the DNA double-strand breaks (DSBs) repair process upstream of the assembly of RAD51 complexes. Required for depletion of HORMAD1 and HORMAD2 from synapsed chromosomes (By similarity). Plays a role in mitotic spindle assembly checkpoint (SAC) activation (PubMed : 28553959).
See full target information TRIP13

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 7:426 PubMed38589567

2024

Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.

Applications

Unspecified application

Species

Unspecified reactive species

Karuna Mittal,Garrett W Cooper,Benjamin P Lee,Yongdong Su,Katie T Skinner,Jenny Shim,Hunter C Jonus,Won Jun Kim,Mihir Doshi,Diego Almanza,Bryan D Kynnap,Amanda L Christie,Xiaoping Yang,Glenn S Cowley,Brittaney A Leeper,Christopher L Morton,Bhakti Dwivedi,Taylor Lawrence,Manali Rupji,Paula Keskula,Stephanie Meyer,Catherine M Clinton,Manoj Bhasin,Brian D Crompton,Yuen-Yi Tseng,Jesse S Boehm,Keith L Ligon,David E Root,Andrew J Murphy,David M Weinstock,Prafulla C Gokhale,Jennifer M Spangle,Miguel N Rivera,Elizabeth A Mullen,Kimberly Stegmaier,Kelly C Goldsmith,William C Hahn,Andrew L Hong

Cell death & disease 15:38 PubMed38216586

2024

Germline specific genes increase DNA double-strand break repair and radioresistance in lung adenocarcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Wenqing Liu,Jan Willem Bruggeman,Qijing Lei,Ans M M van Pelt,Jan Koster,Geert Hamer

Cell reports 40:111297 PubMed36044844

2022

CHAMP1 binds to REV7/FANCV and promotes homologous recombination repair.

Applications

Unspecified application

Species

Unspecified reactive species

Feng Li,Prabha Sarangi,Divya Ramalingam Iyer,Hanrong Feng,Lisa Moreau,Huy Nguyen,Connor Clairmont,Alan D D'Andrea

Proceedings of the National Academy of Sciences of 117:26795-26803 PubMed33051298

2020

p31 promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase.

Applications

Unspecified application

Species

Unspecified reactive species

Prabha Sarangi,Connor S Clairmont,Lucas D Galli,Lisa A Moreau,Alan D D'Andrea

Nature cell biology 22:87-96 PubMed31915374

2020

TRIP13 regulates DNA repair pathway choice through REV7 conformational change.

Applications

Unspecified application

Species

Unspecified reactive species

Connor S Clairmont,Prabha Sarangi,Karthikeyan Ponnienselvan,Lucas D Galli,Isabelle Csete,Lisa Moreau,Guillaume Adelmant,Dipanjan Chowdhury,Jarrod A Marto,Alan D D'Andrea

Journal of experimental & clinical cancer research 38:409 PubMed31533816

2019

Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.

Applications

Unspecified application

Species

Unspecified reactive species

Meng-Xuan Zhu,Chuan-Yuan Wei,Peng-Fei Zhang,Dong-Mei Gao,Jie Chen,Yan Zhao,Shuang-Shuang Dong,Bin-Bin Liu

Nature genetics 49:1148-1151 PubMed28553959

2017

Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation.

Applications

WB

Species

Human

Shawn Yost,Bas de Wolf,Sandra Hanks,Anna Zachariou,Chiara Marcozzi,Matthew Clarke,Richarda de Voer,Banafsheh Etemad,Esther Uijttewaal,Emma Ramsay,Harriet Wylie,Anna Elliott,Susan Picton,Audrey Smith,Sarah Smithson,Sheila Seal,Elise Ruark,Gunnar Houge,Jonathan Pines,Geert J P L Kops,Nazneen Rahman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com